BK5022 Medical Diagnostics & Research
- 553.804
- +5.023+0.92%
Sonic Healthcare Limited's (ASX:SHL) Largest Shareholders Are Retail Investors With 59% Ownership, Institutions Own 37%
Genetic Signatures Appoints Interim CEO
Molecular diagnostics company Genetic Signatures (ASX:GSS) named Neil Gunn as interim CEO following the resignation of John Melki from the role and from the board of directors, according to a Tuesday
1 ASX Dividend Stock to Buy That's Down 40%
The ASX dividend stock Sonic Healthcare Ltd (ASX: SHL) has seen its fair share of pain over the last few years, despite the ongoing growth of the underlying business.
Monash IVF Upgraded to Overweight From Market Weight by Wilsons
Monash IVF Upgraded to Overweight From Market Weight by Wilsons
Monash IVF Price Target Raised 9% to A$1.58/Share by Wilsons
Monash IVF Price Target Raised 9% to A$1.58/Share by Wilsons
Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?
Genetic Signatures' Sales Drop in Fiscal Q3
Genetic Signatures (ASX:GSS) logged sales of AU$1.7 million for the third quarter of fiscal 2024, down from AU$2 million in the year-ago period, according to an April 26 filing with the Australian bou
Genetic Technologies Raises US$2 Million as It Eyes Global Expansion | ASX:GTG, NASDAQ:GENE, OTC:GNTLF
Investors in Integral Diagnostics (ASX:IDX) Have Unfortunately Lost 40% Over the Last Three Years
Rhythm Biosciences Appoints CEO; Shares Down 3%
Rhythm Biosciences (ASX:RHY) appointed David Atkins as chief executive, effective May 13. Atkins has experience across a broad range of life sciences and healthcare disciplines, according to a Wednesd
Microba's Revenue Climbs 297% in Fiscal Q3
Microba Life Sciences' (ASX:MAP) revenue surged 297% year-on-year to AU$4 million in the third fiscal quarter as the medical diagnostics company launched its world-first pathogen test, according to a
These ASX Dividend Winners Keep Giving Investors a Pay Rise
Some ASX dividend shares have been growing their dividend payouts over many years, which is impressive considering the challenges facing the share market in recent times.
Press Release: Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company
Buy These ASX Dividend Shares for Passive Income
Passive income investors that are on the lookout for ASX dividend shares to buy this month could do a lot worse than the three stocks listed below.
Genetic Signatures Secures TGA Approval for Updated EasyScreen Respiratory Pathogen Detection Kit Sale in Australia
Diagnostics company Genetic Signatures (ASX:GSS) obtained authorization from the Therapeutic Goods Administration for the supply of its redesigned EasyScreen Respiratory Pathogen Detection Kit in Aust
Genetic Technologies Raising $2 Million via ADS Offering
Genetic Technologies (ASX:GTG) is seeking to raise $2 million via a registered direct offering of 1 million American depositary shares at $2.00 each. Net proceeds will be used to support sales and mar
INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test
INOVIQ (ASX:IIQ) completed an analytical validation study for its blood test for ovarian cancer, identifying 85% of all samples tested, according to a Friday filing with the Australian Securities Exch
How AI Could Boost This ASX 300 Healthcare Stock
ASX 300 healthcare stock Integral Diagnostics Ltd (ASX: IDX) is up 1.43% to $2.49 per share on Thursday.
Genetic Technologies Launches GeneType Precision Oncology Brand, Diagnostic Tests
Genetic Technologies (ASX:GTG) established a precision oncology division and launched a portfolio of diagnostic tests under its GeneType precision oncology brand, according to a Wednesday filing with
INOVIQ Signs Supply, Distribution Agreement With Promega; Shares Surge 18%
Biotechnology company INOVIQ (ASX:IIQ) and Promega signed a global supply and distribution agreement to harness the economic potential of exosomes for research, diagnostic and therapeutic applications